Siegenfeld, Austria

Christoph Reinisch

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 10.3

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Christoph Reinisch: Innovator in Vaccine Development

Introduction

Christoph Reinisch, a prominent inventor from Siegenfeld, Austria, has made significant contributions to the field of vaccine development. With a portfolio of five patents, he demonstrates his commitment to advancing medical science, particularly in addressing infectious diseases.

Latest Patents

Among Christoph Reinisch's latest innovations are two noteworthy patents. The first, titled "CpG-adjuvanted SARS-CoV-2 virus vaccine," describes novel vaccines and methods for producing and administering these vaccines to individuals in need. This invention aims to enhance immune responses against the SARS-CoV-2 virus. The second patent, "Mutant fragments of OspA and methods and uses relating thereto," focuses on a polypeptide that incorporates a mutant fragment of the outer surface protein A (OspA). This invention includes a pharmaceutical composition intended for treating or preventing infections and outlines methods for immunizing subjects against various pathogens.

Career Highlights

Christoph Reinisch has had an impressive career, working with notable companies in the biotechnology industry. He has contributed to the innovative projects at Valneva Austria GmbH and Dynavax Technologies Corporation, where he honed his skills in vaccine research and development. His work has not only advanced scientific knowledge but also aimed to address critical public health challenges.

Collaborations

Throughout his career, Christoph has collaborated with several esteemed professionals, including Robert Schlegl and Benjamin Wizel. These collaborations have facilitated the exchange of ideas and have played a significant role in the successful development of his innovative projects.

Conclusion

Christoph Reinisch stands out as a key figure in the field of vaccine innovation. His dedication and expertise in developing effective vaccines continue to have a positive impact on global health. Through his patents and collaborations, he demonstrates that innovation in science can lead to significant advancements in healthcare and disease prevention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…